Compare RPTX & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RPTX | SRV |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 180.3M |
| IPO Year | 2020 | N/A |
| Metric | RPTX | SRV |
|---|---|---|
| Price | $2.57 | $40.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 33.9K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,122.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $30.73 |
| 52 Week High | $2.66 | $44.30 |
| Indicator | RPTX | SRV |
|---|---|---|
| Relative Strength Index (RSI) | 74.94 | 51.69 |
| Support Level | $2.15 | $38.11 |
| Resistance Level | $2.66 | $40.30 |
| Average True Range (ATR) | 0.06 | 0.67 |
| MACD | 0.03 | 0.20 |
| Stochastic Oscillator | 83.96 | 94.78 |
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.